[go: up one dir, main page]

DE60104542D1 - Verwendung eines extrazellulären hämoglobins mit höherem molekulargewicht als blutersatz - Google Patents

Verwendung eines extrazellulären hämoglobins mit höherem molekulargewicht als blutersatz

Info

Publication number
DE60104542D1
DE60104542D1 DE60104542T DE60104542T DE60104542D1 DE 60104542 D1 DE60104542 D1 DE 60104542D1 DE 60104542 T DE60104542 T DE 60104542T DE 60104542 T DE60104542 T DE 60104542T DE 60104542 D1 DE60104542 D1 DE 60104542D1
Authority
DE
Germany
Prior art keywords
molecular weight
extra
approximately
higher molecular
blood set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60104542T
Other languages
English (en)
Other versions
DE60104542T2 (de
Inventor
Franck Zal
Andre Toulmond
Francois Lallier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE60104542D1 publication Critical patent/DE60104542D1/de
Publication of DE60104542T2 publication Critical patent/DE60104542T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60104542T 2000-05-31 2001-05-17 Verwendung eines extrazellulären hämoglobins mit höherem molekulargewicht als blutersatz Expired - Lifetime DE60104542T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0007031 2000-05-31
FR0007031A FR2809624B1 (fr) 2000-05-31 2000-05-31 Utilisation comme substitut sanguin d'une hemoglobine extracellulaire de poids moleculaire eleve
PCT/FR2001/001505 WO2001092320A2 (fr) 2000-05-31 2001-05-17 Utilisation comme substitut sanguin d'une hemoglobine extracellulaire de poids moleculaire eleve

Publications (2)

Publication Number Publication Date
DE60104542D1 true DE60104542D1 (de) 2004-09-02
DE60104542T2 DE60104542T2 (de) 2005-09-01

Family

ID=8850865

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60104542T Expired - Lifetime DE60104542T2 (de) 2000-05-31 2001-05-17 Verwendung eines extrazellulären hämoglobins mit höherem molekulargewicht als blutersatz

Country Status (9)

Country Link
US (2) US20030181358A1 (de)
EP (1) EP1284994B1 (de)
JP (1) JP5001500B2 (de)
AT (1) ATE272071T1 (de)
AU (1) AU6243601A (de)
DE (1) DE60104542T2 (de)
DK (1) DK1284994T3 (de)
FR (1) FR2809624B1 (de)
WO (1) WO2001092320A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2860796B1 (fr) * 2003-10-14 2006-02-10 Centre Nat Rech Scient Procede de dissociation de la molecule d'hemoglobine extracellulaire d'arenicola marina, chaines proteiques constituant ladite molecule et sequences nucleotidiques codant pour lesdites chaines proteiques
US7999076B2 (en) * 2006-01-24 2011-08-16 Centre National De La Recherche Use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium
FR2919785B1 (fr) * 2007-08-09 2017-10-20 Hemarina Sa Utilisation d'une globine, d'un protomere de globine ou d'une hemoglobine extracellulaire pour la preservation d'organes, de tissus, ou de cellules d'organes ou de tissus, ou de culture de cellules
NL1035741C2 (en) * 2008-07-23 2010-01-26 Albertus Ide Marie Meijering Extracellular hemoglobin blood substitute derived from ragworm species and the use.
DK2421951T3 (da) * 2009-04-23 2013-08-26 Hemarina Bioreaktor der anvender oxygen-bærende molekyler
US9133431B2 (en) 2009-05-01 2015-09-15 Bimini Technologies Llc Systems, methods and compositions for optimizing tissue and cell enriched grafts
WO2010128159A1 (en) 2009-05-07 2010-11-11 Hemarina Novel heamoglobin and uses thereof
US8273857B2 (en) * 2009-09-22 2012-09-25 Jen-Chang Hsia Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine
FR2991327B1 (fr) 2012-06-05 2018-04-13 Hemarina Procede de lyophilisation d'hemoglobine d'annelides
FR3002146B1 (fr) * 2013-02-15 2016-03-04 Hemarina Utilisation d'hemoglobine d'annelides pour traiter les cancers
FR3005663B1 (fr) * 2013-05-16 2016-02-26 Hemarina Lyophilisat de ver marin et ses utilisations
EP3092213B1 (de) 2013-12-27 2019-10-23 Virginia Commonwealth University Allosterische hämoglobin-modifikatoren mit stickoxidfreisetzendem teil
CL2018002378A1 (es) * 2018-08-20 2018-10-12 Univ Austral De Chile Medicamento útil como sustituto sanguineo para tratar, a la vez, la anemia aguda por pedida de sangre y la infección bacteriana en mamíferos
FR3108842B1 (fr) * 2020-04-02 2022-06-03 Hemarina Utilisation d'hémoglobine d'Annélides pour traiter le syndrome de détresse respiratoire aiguë
WO2022040820A1 (es) * 2020-08-28 2022-03-03 Universidad Austral De Chile Suplemento alimenticio para prevenir la anemia y con efecto orexígeno y vigorizante en animales

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599907A (en) * 1989-05-10 1997-02-04 Somatogen, Inc. Production and use of multimeric hemoglobins
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
IS4198A (is) * 1993-08-13 1995-02-14 Somatogen, Inc Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða
US5929031A (en) * 1995-05-02 1999-07-27 Baxter Biotech Technology Sarl Storage stable hemoglobin solutions

Also Published As

Publication number Publication date
ATE272071T1 (de) 2004-08-15
WO2001092320A2 (fr) 2001-12-06
WO2001092320A3 (fr) 2002-04-04
US20080305178A1 (en) 2008-12-11
EP1284994A2 (de) 2003-02-26
DE60104542T2 (de) 2005-09-01
FR2809624B1 (fr) 2002-08-02
AU6243601A (en) 2001-12-11
JP2004501118A (ja) 2004-01-15
DK1284994T3 (da) 2004-11-29
EP1284994B1 (de) 2004-07-28
US20030181358A1 (en) 2003-09-25
FR2809624A1 (fr) 2001-12-07
JP5001500B2 (ja) 2012-08-15

Similar Documents

Publication Publication Date Title
DE60104542D1 (de) Verwendung eines extrazellulären hämoglobins mit höherem molekulargewicht als blutersatz
DE50207744D1 (de) Pfropfpolymerisate mit stickstoffheterocyclen enthaltenden seitenketten
EP1551834A4 (de) Substituierte quinazolinone verbindungen
TW200631604A (en) Ophthalmic compositions comprising polyether substituted polymers
DE50105552D1 (de) Verwendung hydrophiler pfropfcopolymere mit n-vinylamin- und/oder offenkettigen n-vinylamideinheiten in kosmetischen formulierungen
DK1196444T3 (da) Exendin-4-konjugater og deres medicinske anvendelighed
ATE293799T1 (de) Kontaktlinsenmaterial auf basis von polysiloxanseitenketten enthaltenden makromonomere
ATE478941T1 (de) Vorläuferzellen aus der wharton sulze von humanen nabelschnüren
FI101706B1 (fi) Toiminnallinen rekombinoimalla valmistettu proteiinipolymeeri
WO2003059964A3 (fr) Polymeres supramoleculaires
ATE46527T1 (de) Vertraegliche mischungen von imidiertem acrylpolymer und polyamid und ihre verwendung bei der herstellung von kunststofferzeugnissen.
WO2004060273A3 (en) Skin care composition containing an anionic polymer
NO20000149D0 (no) Olefinpolymersammensetning med lav roekutvikling samt fiber, film og toeystoff fremstilt derfra
ATE283893T1 (de) Verwendung von polyorganosiloxan zur verminderung des cold stress whitenings
AU4178900A (en) Dip-molded medical devices from cis-1,4-polyisoprene
DE59103054D1 (de) Vernetztes, wasserabsorbierendes polymer und verwendung zur herstellung von hygieneartikeln.
ATE123045T1 (de) Polymermischungen mit verbesserten eigenschaften.
ATE361761T1 (de) Poly(ethylen glykol)-konjugate von insulinähnlichem wachstumfaktor bindenden protein-4
DE602006005233D1 (de) Verfahren zur behandlung von haar mit einem mizellaren vernetzten copolymer
DE69914869D1 (de) Hochtransparente Polymerzusammensetzung
ATE222085T1 (de) Kosmetische zusammensetzung auf der basis von assoziativen polyurethanen und anionischen polymeren mit fettketten
DE69120925D1 (de) Hämoglobin-oligomer basierte komposition und seine herstellung
ATE309318T1 (de) Verwendung von verbindungen in waschmitteln
ATE391933T1 (de) Elektrobenetzungssystem mit elektrolytlösung von hoher zuverlässigkeit
Gessain et al. Genetic diversity and molecular epidemiology of primate T cell lymphotropic viruses: human T cell leukaemia/lymphoma viruses types 1 and 2 and related simian retroviruses (STLV-1, STLV-2 pan-p and PTLV-L)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition